Expert Opinion on Drug Metabolism and Toxicology
Taylor and Francis Ltd.
United Kingdom
journal
SJR by Edition
Subject Categories
- Medicine (miscellaneous)Q1
- ToxicologyQ1
- PharmacologyQ2
Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics
Most published research topics
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
1742-5255, 1744-7607
SJR Best Quartile
Q1
Region
Western Europe
Citations per Document (2 years)
4.52
References per Document
84.62
Coverage
2005-2026
Scope
Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data. Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug. The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.
Metrics from SCImago Journal Rank 2025. View on SCImago